NHS-IL12, a Tumor-Targeting Immunocytokine by Greiner JW, Morillon II YM, Schlom J

“…ImmunoTargets and Therapy…”
Get full text

Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response by Dejaegher J, Van Gool S, De Vleeschouwer S

“…ImmunoTargets and Therapy…”
Get full text

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon? by Passiglia F, Reale ML, Cetoretta V, Novello S

“…ImmunoTargets and Therapy…”
Get full text

Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases by Tanaka Y, Hoshino-Negishi K, Kuboi Y, Tago F, Yasuda N, Imai T

“…ImmunoTargets and Therapy…”
Get full text

Complement Inhibition and COVID-19: The Story so Far by Fodil S, Annane D

“…ImmunoTargets and Therapy…”
Get full text

Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer by Scholz M, Yep S, Chancey M, Kelly C, Chau K, Turner J, Lam R, Drake CG

“…ImmunoTargets and Therapy…”
Get full text

Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis) by Cauli A, Piga M, Floris A, Mathieu A

“…ImmunoTargets and Therapy…”
Get full text

FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights by Krakauer T

“…ImmunoTargets and Therapy…”
Get full text

Therapeutic cancer vaccines and combination immunotherapies involving vaccination by Nguyen T, Urban J, Kalinski P

“…ImmunoTargets and Therapy…”
Get full text

Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer's disease by Lambracht-Washington D, Rosenberg RN

“…ImmunoTargets and Therapy…”
Get full text

T cell immunoglobulin domain and mucin domain-3 as an emerging target for immunotherapy in cancer management by Yoneda A, Jinushi M

“…ImmunoTargets and Therapy…”
Get full text

Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies by Hutter C, Minkov M

“…ImmunoTargets and Therapy…”
Get full text

Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma by Bughda R, Dimou P, D'Souza RR, Klampatsa A

“…ImmunoTargets and Therapy…”
Get full text

Males’ Access to Human Papillomavirus Vaccination in Resource-Limited Settings by Gezimu W, Bekele F, Bekana T, Demeke A

“…ImmunoTargets and Therapy…”
Get full text

Dermatomyositis: Practical Guidance and Unmet Needs by Cassard L, Seraly N, Riegert M, Patel A, Fernandez AP

“…ImmunoTargets and Therapy…”
Get full text

Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications by Lillo AM, Velappan N, Kelliher JM, Watts AJ, Merriman SP, Vuyisich G, Lilley LM, Coombs KE, Mastren T, Teshima M, Stein BW, Wagner GL, Iyer S, Bradbury ARM, Harris JF, Dichosa AE, Kozimor SA

“…ImmunoTargets and Therapy…”
Get full text

Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Repl... by Jiang J, Wang Y, Liu D, Wang X, Zhu Y, Tong J, Chen E, Xue L, Zhao N, Liang T, Zheng C

“…ImmunoTargets and Therapy…”
Get full text

Targeting Prostate Cancer Using Intratumoral Cytotopically Modified Interleukin-15 Immunotherapy in a Syngeneic Murine Model by Papaevangelou E, Smolarek D, Smith RA, Dasgupta P, Galustian C

“…ImmunoTargets and Therapy…”
Get full text

Comprehension of Calcitriol Levels in Pregnant Women With Latent Tuberculosis and Immune Function in their Newborns by Meirina F, Sari DK, Lubis IND, Daulay RS, Yani FF, Lubis BM, Sembiring RJ, Pandia P, Rusda M, Amin MM

“…ImmunoTargets and Therapy…”
Get full text

Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update by Guallar-Garrido S, Julián E

“…ImmunoTargets and Therapy…”
Get full text